Diabetic Kidney Disease and the Cardiorenal Syndrome. Old Disease, New Perspectives

JindalA.; Garcia-TouzaM.; JindalN.; Whaley-ConnellA.; SowersJ.R.

首页> 外文期刊>Endocrinology and Metabolism Clinics of North America >Diabetic Kidney Disease and the Cardiorenal Syndrome. Old Disease, New Perspectives

【24h】

Diabetic Kidney Disease and the Cardiorenal Syndrome. Old Disease, New Perspectives

机译：糖尿病肾病和心肾综合征。旧病，新观点

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In this article, the literature is reviewed regarding the role of blood pressure variability and nocturnal nondipping of blood pressure as well as the presence of diabetic kidney disease (DKD), in the absence of albuminuria, as risk predictors for progressive DKD. The importance of glycemic and blood pressure control in patients with diabetes and chronic kidney disease, and the use of oral hypoglycemic agents and antihypertensive agents in this patient cohort, are also discussed.

机译：在本文中，综述了在无蛋白尿的情况下血压变异性和夜间血压的非浸入以及糖尿病肾病（DKD）的作用作为进行性DKD的风险预测因素的文献。还讨论了在糖尿病和慢性肾脏病患者中控制血糖和血压的重要性，以及在该患者队列中使用口服降糖药和降压药的重要性。

著录项

来源
《Endocrinology and Metabolism Clinics of North America》 |2013年第4期|共20页
作者
JindalA.; Garcia-TouzaM.; JindalN.; Whaley-ConnellA.; SowersJ.R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Albuminuria; Blood pressure variability; Cardiorenal syndrome; Chronic kidney disease; Diabetes; Diabetic nephropathy; Proteinuria;

机译：蛋白尿;血压变异性;心肾综合征;慢性肾脏病;糖尿病;糖尿病肾病;蛋白尿;

相似文献

外文文献
中文文献
专利

1. Diabetic Kidney Disease and the Cardiorenal Syndrome. Old Disease, New Perspectives [J] . JindalA., Garcia-TouzaM., JindalN., Endocrinology and Metabolism Clinics of North America . 2013,第4期

机译：糖尿病肾病和心肾综合征。旧病，新观点
2. SAT-305 EFFECTS OF EMPAGLIFLOZIN VS PLACEBO ON CARDIORENAL OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES AND PROTEINURIC DIABETIC KIDNEY DISEASE: INSIGHTS FROM EMPA-REG OUTCOME [J] . C. Wanner MD, B. Zinman, M. von Eynatten, Kidney International Reports . 2019,第7期

机译：SAT-305恩帕格列净vs替卡波对2型糖尿病和蛋白尿型糖尿病肾脏疾病患者心脏结局的影响：对EMPA-REG结果的见解
3. Effects of empagliflozin on cardiorenal outcomes in patients with type 2 diabetes and proteinuric diabetic kidney disease: insights from EMPA-REG OUTCOME [J] . Wanner Christoph, Zinman Bernard, von Eynatten Maximilian, Diabetes/metabolism research and reviews . 2019,第S1期

机译：Empagliflozin对2型糖尿病和蛋白糖尿病肾疾病患者心血管结果的影响：EMPA-REG结果的见解
4. The impact of diabetic HbA1c exam on the occurrence of chronic kidney disease in type 2 diabetic patients [C] . Pi-I Li, Chih-Ching Chang Annual conference of the International Society of Exposure Science . 2014

机译：糖尿病HbA1c检查对2型糖尿病患者慢性肾脏疾病发生的影响
5. Annual Out-Of-Pocket Costs and Productivity Loss Among Patients with Diabetic Kidney Disease Compared to Type 2 Diabetes Mellitus [D] . ?Cha, Ashley Soojin 2020

机译：与2型糖尿病相比，糖尿病肾脏疾病患者的年度超港元和生产力丧失
6. Diabetic Kidney Disease and the Cardiorenal syndrome: Old Disease New Perspectives [O] . Ankur Jindal, Mariana Garcia-Touza, Nidhi Jindal, -1

机译：糖尿病肾病和心肾综合征：旧病新观点
7. Cardiorenal Protection in Diabetic Kidney Disease [O] . Jason F. Lee, Ecaterina Berzan, Vikas S. Sridhar, 2021

机译：糖尿病肾疾病中的心肺保护

Diabetic Kidney Disease and the Cardiorenal Syndrome. Old Disease, New Perspectives

摘要

著录项

相似文献

相关主题

期刊订阅